Literature DB >> 17167050

Identification of alterations in DNA copy number in host stromal cells during tumor progression.

Robert J Pelham1, Linda Rodgers, Ira Hall, Robert Lucito, Ken C Q Nguyen, Nicholas Navin, James Hicks, David Mu, Scott Powers, Michael Wigler, David Botstein.   

Abstract

The interactions between cancer cells and the surrounding host stromal tissue play a critical role in tumor progression and metastasis, but the molecular nature of this relationship remains largely uncharacterized. Furthermore, although genetic changes of neoplastic cells in tumors contribute significantly to tumor progression, it is not known whether similar changes occur in the adjacent host stromal microenvironment and whether they contribute to or inhibit tumorigenesis. To address this question in an unbiased and genome-wide manner, we applied high-resolution DNA copy number analysis to murine stromal DNA isolated from human xenograft tumors that were formed in immunodeficient mice. We show that numerous amplifications and deletions are found within the host stromal microenvironment, suggesting that alterations in host DNA copy number can occur and may play a significant role in modifying tumor-stromal interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167050      PMCID: PMC1698871          DOI: 10.1073/pnas.0609635104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.

Authors:  Jianying Dong; Jeremy Grunstein; Max Tejada; Frank Peale; Gretchen Frantz; Wei-Ching Liang; Wei Bai; Lanlan Yu; Joe Kowalski; Xiaohuan Liang; Germaine Fuh; Hans-Peter Gerber; Napoleone Ferrara
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

2.  Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease.

Authors:  T Goossens; U Klein; R Küppers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.

Authors:  Koichi Fukino; Lei Shen; Satoshi Matsumoto; Carl D Morrison; George L Mutter; Charis Eng
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

Review 4.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

5.  Large-scale copy number polymorphism in the human genome.

Authors:  Jonathan Sebat; B Lakshmi; Jennifer Troge; Joan Alexander; Janet Young; Pär Lundin; Susanne Månér; Hillary Massa; Megan Walker; Maoyen Chi; Nicholas Navin; Robert Lucito; John Healy; James Hicks; Kenny Ye; Andrew Reiner; T Conrad Gilliam; Barbara Trask; Nick Patterson; Anders Zetterberg; Michael Wigler
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

6.  Molecular characterization of the tumor microenvironment in breast cancer.

Authors:  Minna Allinen; Rameen Beroukhim; Li Cai; Cameron Brennan; Jaana Lahti-Domenici; Haiyan Huang; Dale Porter; Min Hu; Lynda Chin; Andrea Richardson; Stuart Schnitt; William R Sellers; Kornelia Polyak
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

7.  EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer.

Authors:  Weiguang Mao; Elizabeth Luis; Sarajane Ross; Johnny Silva; Christine Tan; Craig Crowley; Clarissa Chui; Gretchen Franz; Peter Senter; Hartmut Koeppen; Paul Polakis
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

8.  Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.

Authors:  Hanna Tuhkanen; Maarit Anttila; Veli-Matti Kosma; Seppo Ylä-Herttuala; Seppo Heinonen; Arja Kuronen; Matti Juhola; Raija Tammi; Markku Tammi; Arto Mannermaa
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

9.  Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.

Authors:  Ryan F Paterson; Thomas M Ulbright; Gregory T MacLennan; Shaobo Zhang; Chong-Xian Pan; Christopher J Sweeney; Curtiss R Moore; Richard S Foster; Michael O Koch; John N Eble; Liang Cheng
Journal:  Cancer       Date:  2003-11-01       Impact factor: 6.860

10.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029

View more
  18 in total

1.  Cancer-associated fibroblasts derived from EGFR-TKI-resistant tumors reverse EGFR pathway inhibition by EGFR-TKIs.

Authors:  Sheldon R Mink; Surabhi Vashistha; Wenxuan Zhang; Amanda Hodge; David B Agus; Anjali Jain
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

Review 2.  A systems biology approach to defining metastatic biomarkers and signaling pathways.

Authors:  Natalie E Goldberger; Kent W Hunter
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

3.  Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo.

Authors:  David M Goldenberg; David Zagzag; Kerstin M Heselmeyer-Haddad; Lissa Y Berroa Garcia; Thomas Ried; Meiyu Loo; Chien-Hsing Chang; David V Gold
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

4.  T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer.

Authors:  Dandan Li; Nicholas Schaub; Theresa M Guerin; Tashinga E Bapiro; Frances M Richards; Vicky Chen; Keyur Talsania; Parimal Kumar; Debra J Gilbert; Jerome J Schlomer; Seong-Jin Kim; Rebecca Sorber; Yaroslav Teper; Wendy Bautista; Claudia Palena; Chan-Young Ock; Duncan I Jodrell; Nathan Pate; Monika Mehta; Yongmei Zhao; Serguei Kozlov; Udo Rudloff
Journal:  Mol Cancer Ther       Date:  2021-08-10       Impact factor: 6.009

5.  Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.

Authors:  Bow J Tauro; Rommel A Mathias; David W Greening; Shashi K Gopal; Hong Ji; Eugene A Kapp; Bradley M Coleman; Andrew F Hill; Ulrike Kusebauch; Janice L Hallows; David Shteynberg; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2013-05-03       Impact factor: 5.911

6.  In vivo evolution of tumor-derived endothelial cells.

Authors:  Terence F McGuire; Gangadharan B Sajithlal; Jie Lu; Robert D Nicholls; Edward V Prochownik
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 7.  Migratory neighbors and distant invaders: tumor-associated niche cells.

Authors:  Jared Wels; Rosandra N Kaplan; Shahin Rafii; David Lyden
Journal:  Genes Dev       Date:  2008-03-01       Impact factor: 11.361

8.  Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.

Authors:  Richard S Maser; Bhudipa Choudhury; Peter J Campbell; Bin Feng; Kwok-Kin Wong; Alexei Protopopov; Jennifer O'Neil; Alejandro Gutierrez; Elena Ivanova; Ilana Perna; Eric Lin; Vidya Mani; Shan Jiang; Kate McNamara; Sara Zaghlul; Sarah Edkins; Claire Stevens; Cameron Brennan; Eric S Martin; Ruprecht Wiedemeyer; Omar Kabbarah; Cristina Nogueira; Gavin Histen; Jon Aster; Marc Mansour; Veronique Duke; Letizia Foroni; Adele K Fielding; Anthony H Goldstone; Jacob M Rowe; Yaoqi A Wang; A Thomas Look; Michael R Stratton; Lynda Chin; P Andrew Futreal; Ronald A DePinho
Journal:  Nature       Date:  2007-05-21       Impact factor: 49.962

9.  Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.

Authors:  David M Goldenberg; David V Gold; Meiyu Loo; Donglin Liu; Chien-Hsing Chang; Elaine S Jaffe
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine.

Authors:  A C Dudley; S-C Shih; A R Cliffe; K Hida; M Klagsbrun
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.